A surprise announcement from Google DeepMind triggered a sector-wide sell-off, hitting mobile gaming and ad-tech stocks. Analysts debate the long-term implications for companies like AppLovin.
The collapse of Big Rock Sports, a major behind-the-scenes distributor for hunting and fishing retailers, marks another casualty in the sporting goods sector's struggle against e-commerce dominance and shifting consumer habits.
Facing what CEO Peter Vanacker calls the 'deepest and longest downturn' of his career, LyondellBasell reported Q1 2025 results while detailing a new $500 million cash improvement plan. The chemical giant is leaning into portfolio restructuring and its global supply network to weather trade policy uncertainty and weak demand.
Elon Musk is reportedly in discussions to merge his aerospace giant SpaceX with his artificial intelligence venture xAI, aiming to create an integrated powerhouse for deploying AI data centers in orbit, powered by space solar energy.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
A proposed near-zero payment increase for Medicare Advantage plans by the Trump administration has blindsided Wall Street, erasing billions in market value and raising fears of a prolonged downturn for major health insurers.
Millions of Social Security beneficiaries will see their February payments arrive on schedule, with amounts reflecting this year's cost-of-living adjustment. Here is the complete calendar and key details.
American Express reported fourth-quarter earnings that narrowly missed analyst forecasts, yet a modest stock decline reflects investor confidence in its robust guidance and the sustained momentum of its high-end cardmember base.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
Shares of Allison Transmission Holdings (ALSN) have surged over 35% in three months, reigniting a fierce debate among analysts over whether the stock is overvalued or still trading at a deep discount to its future cash flows.
Following a period of strong sales growth, Chili's Grill & Bar is laying the groundwork to potentially grant its general managers a greater ownership stake, a move inspired by industry leaders like Texas Roadhouse and Raising Cane's.
Social media investigations reveal widespread weight mislabeling on Walmart meat products, prompting potential legal action and raising questions about pricing integrity at the retail giant.
New satellite imagery shows Iran constructing roofs over bomb-damaged buildings at its Isfahan and Natanz nuclear facilities, a move analysts say is likely aimed at shielding recovery efforts from surveillance as international pressure mounts over Tehran's internal crackdown and nuclear ambitions.
Despite posting quarterly results that beat analyst expectations, KLA Corporation's stock plunged Friday as investors focused on management warnings about component shortages, tariff impacts, and operational constraints.
U.S. producer prices rose more than expected in December, driven by the largest increase in service costs in months, complicating the inflation outlook as the Federal Reserve weighs its next policy move.
Charter Communications shares surged Friday after the cable giant reported a rare quarterly gain in pay-TV subscribers, a bright spot amid ongoing broadband pressures. The company's strategy of bundling streaming services appears to be resonating with customers.
As sky-high valuations plague pure-play AI stocks, a global industrial landlord is emerging as a critical—and potentially undervalued—enabler of the artificial intelligence boom through its strategic pivot into data centers.
Regeneron Pharmaceuticals reported a steady finish to 2025, driven by growth in key drugs Dupixent and EYLEA HD. While navigating competitive pressures on its legacy blockbuster, the biotech giant outlined an ambitious 2026 strategy focused on regulatory milestones and a broad clinical pipeline.
Primis Financial (FRST) posted Q4 earnings of $29.5M, buoyed by a one-time gain. Management pegs core quarterly earnings near $8M, citing mortgage growth and deposit mix improvements as key drivers for its 2026 profitability target.
RLI Corp's latest earnings report showcases robust underwriting performance and capital returns. However, a mixed share price trajectory and premium valuation metrics are prompting investors to question whether the stock's future growth is already priced in.
